BioSpace News Archive

Preparing for Your Annual Performance Review

Accomplishments are integral to the aspects of the annual performance review. And here’s how to prepare for review to admit a good performance record in the company.

November 11, 2019
·
4 min read
·
Katharine Hansen, PhD
Deals

Foamix and Menlo Therapeutics Combine to Form Single Dermatology Company

The merged company will be led by David Domzalski, current chief executive officer of Foamix. It will be headquartered in New Jersey.

November 11, 2019
·
2 min read
·
Mark Terry
Biotech Bay

Genentech Eyes Potential Approval of SMA Drug After Positive Trial Results

Genentech announced this morning that its experimental SMA drug risdiplam hit the mark in the second part of the pivotal SUNFISH study of patients with Type 2 and 3 of the disease.

November 11, 2019
·
3 min read
·
Alex Keown
Business

World AMR Congress: Fighting Anti-Microbial Resistance

The World Anti-Microbial Resistance Congress 2019 was held November 7-8 in Washington, D.C.

November 11, 2019
·
6 min read
·
Mark Terry
Policy

F2G Receives US FDA Breakthrough Therapy Designation for Olorofim

In Phase 2b development for the treatment of life-threatening fungal infections

November 11, 2019
·
4 min read
ORYX Confirms ParvOryx Mode of Action in Tumor Explant Model

ORYX, a translational medicine company focused on oncolytic virotherapy and cancer vaccines, reported new results on the mode of action of oncolytic virus ParvOryx in human ovarian cancer explants.

November 11, 2019
·
4 min read
Business

LEO Pharma announces agreement with Ubiquigent to access novel compounds

Ubiquigent Limited and LEO Pharma A/S announced that they have entered into an option agreement granting LEO Pharma access to two novel compounds.

November 11, 2019
·
3 min read
Chi-Med to Attend Upcoming November and December 2019 Investor and Industry Conferences

London: Monday, November 11, 2019: Hutchison China MediTech Limited announces that Christian Hogg, Chief Executive Officer, will present at the following conferences

November 11, 2019
·
3 min read
Drug Development

ASLAN’s Varlitinib Fails Biliary Tract Cancer Trial

The drug failed to meet the primary endpoints of progression-free survival and overall response rate.

November 11, 2019
·
3 min read
·
Mark Terry
Biotech Bay

Cofactor Genomics Opens Early Access to New T Cell Exhaustion Models through Predictive Immune Modeling Platform

Announces “Functional to FFPE” Early-Access Grant Program

November 11, 2019
·
3 min read